{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:12:34Z","timestamp":1791033154754,"version":"4.1.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["Benificiary id-342712"],"award-info":[{"award-number":["Benificiary id-342712"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["VIR\/5\/2019\/ECD-1"],"award-info":[{"award-number":["VIR\/5\/2019\/ECD-1"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49711-9","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:48:27Z","timestamp":1777366107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prediction of potential NS3-based T cell epitopes of hepatitis C virus by in-silico and in-vitro approach"],"prefix":"10.1038","volume":"16","author":[{"given":"Supradip","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amlanjyoti","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghamala","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Ghose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moumita","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagnik","family":"Bakshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raina","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyasi","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwesha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Provash Chandra","family":"Sadhukhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"49711_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14218\/JCTH.2017.00067","volume":"6","author":"P Axley","year":"2018","unstructured":"Axley, P., Ahmed, Z., Ravi, S. & Singal, A. K. Hepatitis C virus and hepatocellular carcinoma: a narrative review. J. Clin. Transl Hepatol. 6, 79\u201384 (2018).","journal-title":"J. Clin. Transl Hepatol."},{"key":"49711_CR2","unstructured":"World Health Organization. Hepatitis C Fact Sheet  (2022). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"49711_CR3","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3389\/fmicb.2019.00814","volume":"10","author":"M Ye","year":"2019","unstructured":"Ye, M. et al. Identification of a new HCV subtype 6xg among injection drug users in kachin, myanmar. Front. Microbiol. 10, 814 (2019).","journal-title":"Front. Microbiol."},{"key":"49711_CR4","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/infdis\/jiy401","volume":"218","author":"SM Borgia","year":"2018","unstructured":"Borgia, S. M. et al. Identification of a novel hepatitis C virus genotype from Punjab, India: expanding classification of hepatitis C virus into 8 genotypes. J. Infect. Dis. 218, 1722\u20131729 (2018).","journal-title":"J. Infect. Dis."},{"key":"49711_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3892\/ijmm.2012.1209","volume":"31","author":"Q Cai","year":"2013","unstructured":"Cai, Q., Zhao, Z., Liu, Y., Shao, X. & Gao, Z. Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay. Int. J. Mol. Med. 31, 347\u2013352 (2013).","journal-title":"Int. J. Mol. Med."},{"key":"49711_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40265-016-0685-x","volume":"77","author":"A Chan","year":"2017","unstructured":"Chan, A., Patel, K. & Naggie, S. Genotype 3 infection\u2013 the last stand of hepatitis C virus. Drugs 77, 131 (2017).","journal-title":"Drugs"},{"key":"49711_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/jmv.24921","volume":"90","author":"S Mahmud","year":"2018","unstructured":"Mahmud, S. et al. Hepatitis C virus genotypes in the Middle East and North Africa: distribution, diversity, and patterns. J. Med. Virol. 90, 131\u2013141 (2018).","journal-title":"J. Med. Virol."},{"key":"49711_CR8","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.ijid.2012.05.086","volume":"16","author":"Y Poovorawan","year":"2012","unstructured":"Poovorawan, Y. Epidemiology of hepatitis C virus - genotypes 1 through 6 in Asia and the world. Int. J. Infect. Dis. 16, e33 (2012).","journal-title":"Int. J. Infect. Dis."},{"key":"49711_CR9","doi-asserted-by":"crossref","unstructured":"Lin, S. K. et al. Using host genetics to infer the global spread and evolutionary history of HCV subtype 3a. Virus Evol. 7, 1452 (2021).","DOI":"10.1093\/ve\/veab065"},{"key":"49711_CR10","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.3748\/wjg.v13.i17.2406","volume":"13","author":"J Dubuisson","year":"2007","unstructured":"Dubuisson, J. Hepatitis C virus proteins. World J. Gastroenterol.: WJG. 13, 2406 (2007).","journal-title":"World J. Gastroenterol.: WJG"},{"key":"49711_CR11","doi-asserted-by":"crossref","unstructured":"Tamori, A., Enomoto, M. & Kawada, N. Recent advances in antiviral therapy for chronic Hepatitis C. Mediators Inflamm  (2016).","DOI":"10.1155\/2016\/6841628"},{"key":"49711_CR12","unstructured":"Core Concepts - Treatment of HCV Genotype. 3 - Treatment of Chronic Hepatitis C Infection - Hepatitis C Online (2025). https:\/\/www.hepatitisc.uw.edu\/go\/treatment-infection\/treatment-genotype-3\/core-concept\/all."},{"key":"49711_CR13","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","volume":"368","author":"E Lawitz","year":"2013","unstructured":"Lawitz, E. et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl. J. Med. 368, 1878\u20131887 (2013).","journal-title":"N Engl. J. Med."},{"key":"49711_CR14","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1007\/s00705-015-2535-7","volume":"160","author":"J Guan","year":"2015","unstructured":"Guan, J. et al. Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice. Arch. Virol. 160, 2517\u20132524 (2015).","journal-title":"Arch. Virol."},{"key":"49711_CR15","doi-asserted-by":"publisher","first-page":"9637","DOI":"10.1021\/bi047437u","volume":"44","author":"G Maga","year":"2005","unstructured":"Maga, G. et al. Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663. Biochemistry 44, 9637\u20139644 (2005).","journal-title":"Biochemistry"},{"key":"49711_CR16","doi-asserted-by":"crossref","unstructured":"Tan, S. L., Pause, A., Shi, Y. & Sonenberg, N. Hepatitis C therapeutics: current status and emerging strategies. Nat. Rev. Drug Discov. 1, 867\u2013881 (2002).","DOI":"10.1038\/nrd937"},{"key":"49711_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/thalassrep13030016","volume":"13","author":"S Dutta","year":"2023","unstructured":"Dutta, S. et al. Molecular epidemiology of HCV infection among multi-transfused \u03b2-Thalassemia patients in Eastern India: a six-year observation. Thalassemia Rep. 13, 165\u2013178 (2023).","journal-title":"Thalassemia Rep."},{"key":"49711_CR18","doi-asserted-by":"publisher","first-page":"42851","DOI":"10.1038\/srep42851","volume":"7","author":"G Nagpal","year":"2017","unstructured":"Nagpal, G. et al. Computer-aided designing of immunosuppressive peptides based on IL-10 inducing potential. Sci. Rep. 7, 42851 (2017).","journal-title":"Sci. Rep."},{"key":"49711_CR19","doi-asserted-by":"crossref","unstructured":"Dhanda, S. K., Gupta, S., Vir, P. & Raghava, G. P. S. Prediction of IL4 inducing peptides. Clin. Dev. Immunol.  2013, 1\u20139 (2013).","DOI":"10.1155\/2013\/263952"},{"key":"49711_CR20","doi-asserted-by":"publisher","first-page":"W431","DOI":"10.1093\/nar\/gkv495","volume":"43","author":"H Lee","year":"2015","unstructured":"Lee, H., Heo, L., Lee, M. S. & Seok, C. GalaxyPepDock: a protein\u2013peptide docking tool based on interaction similarity and energy optimization. Nucleic Acids Res. 43, W431\u2013W435 (2015).","journal-title":"Nucleic Acids Res."},{"key":"49711_CR21","doi-asserted-by":"crossref","unstructured":"Heo, L., Lee, H. & Seok, C.  Galaxy refine complex refinement of protein-protein complex model structures driven by interface repacking. Sci. Rep. 6, 32153 (2016).","DOI":"10.1038\/srep32153"},{"key":"49711_CR22","doi-asserted-by":"crossref","unstructured":"Lefort, C. T. & Kim, M. Human T lymphocyte isolation, culture and analysis of migration. In Vitro J. Visual. Exp.   (2010).","DOI":"10.3791\/2017-v"},{"key":"49711_CR23","doi-asserted-by":"publisher","unstructured":"Raulf, M. T.   Cell primary culture from peripheral blood.   Vaccine 2019, 17\u201331.  https:\/\/doi.org\/10.1007\/978-1-4939-9591-2_2  (2019).","DOI":"10.1007\/978-1-4939-9591-2_2"},{"key":"49711_CR24","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1016\/j.vaccine.2014.03.083","volume":"32","author":"S Mishra","year":"2014","unstructured":"Mishra, S. et al. Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of na\u00efve human T cells. Vaccine 32, 3285\u20133292 (2014).","journal-title":"Vaccine"},{"key":"49711_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/hmg\/10.8.881","volume":"10","author":"P Zavattari","year":"2001","unstructured":"Zavattari, P. Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 diabetes risk encoded by the major HLA-DQB1, -DRB1 disease loci. Hum. Mol. Genet. 10, 881\u2013889 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"49711_CR26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1034\/j.1399-0039.2001.580504.x","volume":"58","author":"SK Cordovado","year":"2001","unstructured":"Cordovado, S. K., Simone, A. E. & Mueller, P. W. High-resolution sequence\u2010based typing strategy for HLA\u2010DQA1 using SSP\u2010PCR and subsequent genotyping analysis with novel spreadsheet program. Tissue Antigens. 58, 308\u2013314 (2001).","journal-title":"Tissue Antigens"},{"key":"49711_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/09723757.2009.11886074","volume":"9","author":"B Singh","year":"2009","unstructured":"Singh, B., Mallick, G. C., Bandopadhyay, S., Nayak, C. R. & Chaudhuri, T. K. Study of selected HLA-A and-B antigens by PCR-SSP method in Bengali population of Siliguri and adjoining areas of West Bengal. Int. J. Hum. Genet. 9, 245\u2013249 (2009).","journal-title":"Int. J. Hum. Genet."},{"key":"49711_CR28","doi-asserted-by":"publisher","first-page":"10961","DOI":"10.1073\/pnas.93.20.10961","volume":"93","author":"R Arguello","year":"1996","unstructured":"Arguello, R., Avakian, H., Goldman, J. M. & Madrigal, J. A. A novel method for simultaneous high resolution identification of HLA-A, HLA-B, and HLA-Cw alleles. Proc. Natl. Acad. Sci. U S A. 93, 10961 (1996).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"49711_CR29","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1080\/21645515.2015.1094595","volume":"12","author":"P Oyarz\u00fan","year":"2016","unstructured":"Oyarz\u00fan, P. & Kobe, B. Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production. Hum. Vaccin. Immunother. 12, 763\u2013767 (2016).","journal-title":"Hum. Vaccin. Immunother."},{"key":"49711_CR30","doi-asserted-by":"publisher","first-page":"705974","DOI":"10.3389\/fimmu.2021.705974","volume":"12","author":"A Nelde","year":"2021","unstructured":"Nelde, A. et al. Immunopeptidomics-guided warehouse design for peptide-based immunotherapy in chronic lymphocytic leukemia. Front. Immunol. 12, 705974 (2021).","journal-title":"Front. Immunol."},{"key":"49711_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bj.2020.09.005","volume":"44","author":"HX Lim","year":"2021","unstructured":"Lim, H. X., Lim, J., Jazayeri, S. D., Poppema, S. & Poh, C. L. Development of multi-epitope peptide-based vaccines against SARS-CoV-2. Biomed. J. 44, 18\u201330 (2021).","journal-title":"Biomed. J."},{"key":"49711_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1747-0285.2009.00825.x","volume":"74","author":"DJ Kao","year":"2009","unstructured":"Kao, D. J. & Hodges, R. S. Advantages of a synthetic peptide immunogen over a protein immunogen in the development of an anti\u2010pilus vaccine for  Pseudomonas aeruginosa. Chem. Biol. Drug Des. 74, 33\u201342 (2009).","journal-title":"Chem. Biol. Drug Des."},{"key":"49711_CR33","doi-asserted-by":"publisher","unstructured":"De Groot, A. S., Moise, L., McMurry, J. A. & Martin, W. Epitope-Bbased immunome-derived vaccines: a strategy for improved design and safety. In Clinical Applications of Immunomics 39\u201369 (Springer US,  2009). https:\/\/doi.org\/10.1007\/978-0-387-79208-8_3.","DOI":"10.1007\/978-0-387-79208-8_3"},{"key":"49711_CR34","doi-asserted-by":"publisher","first-page":"e0142563","DOI":"10.1371\/journal.pone.0142563","volume":"10","author":"H Ghaffari-Nazari","year":"2015","unstructured":"Ghaffari-Nazari, H. et al. Improving multi-epitope long peptide vaccine potency by using a strategy that enhances CD4+ T help in BALB\/c mice. PLoS One. 10, e0142563 (2015).","journal-title":"PLoS One"},{"key":"49711_CR35","doi-asserted-by":"crossref","unstructured":"Mekonnen, Z. A. et al. Enhanced T cell responses induced by a necrotic dendritic cell vaccine, expressing HCV NS3. Front. Microbiol. 11, 2563  (2020).","DOI":"10.3389\/fmicb.2020.559105"},{"key":"49711_CR36","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0140-6736(95)91691-1","volume":"346","author":"HM Diepolder","year":"1995","unstructured":"Diepolder, H. M. et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346, 1006\u20131007 (1995).","journal-title":"Lancet"},{"key":"49711_CR37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/jhep.2003.50115","volume":"37","author":"AM Wertheimer","year":"2003","unstructured":"Wertheimer, A. M. et al. Novel CD4\u2009+\u2009and CD8\u2009+\u2009T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 37, 577\u2013589 (2003).","journal-title":"Hepatology"},{"key":"49711_CR38","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","volume":"194","author":"R Thimme","year":"2001","unstructured":"Thimme, R. et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194, 1395\u20131406 (2001).","journal-title":"J. Exp. Med."},{"key":"49711_CR39","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/75063","volume":"6","author":"A Takaki","year":"2000","unstructured":"Takaki, A. et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 6, 578\u2013582 (2000).","journal-title":"Nat. Med."},{"key":"49711_CR40","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.4049\/jimmunol.169.6.3447","volume":"169","author":"H Wedemeyer","year":"2002","unstructured":"Wedemeyer, H. et al. Impaired effector function of hepatitis C virus-specific CD8\u2009+\u2009T cells in chronic hepatitis C virus infection. J. Immunol. 169, 3447\u20133458 (2002).","journal-title":"J. Immunol."},{"key":"49711_CR41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1056\/NEJMoa2023345","volume":"384","author":"K Page","year":"2021","unstructured":"Page, K. et al. Randomized trial of a vaccine regimen to prevent chronic HCV infection. N. Engl. J. Med. 384, 541\u2013549 (2021).","journal-title":"N. Engl. J. Med."},{"key":"49711_CR42","unstructured":"National Institutes of Health (NIH). Trial evaluating experimental hepatitis C vaccine concludes. NIH news release (2019). https:\/\/www.niaid.nih.gov\/news-events\/trial-evaluating-experimental-hepatitis-c-vaccine-concludes)."},{"key":"49711_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1128\/CMR.16.2.209-219.2003","volume":"16","author":"H Friedman","year":"2003","unstructured":"Friedman, H., Newton, C. & Klein, T. W. Microbial infections, immunomodulation, and drugs of abuse. Clin. Microbiol. Rev. 16, 209\u2013219 (2003).","journal-title":"Clin. Microbiol. Rev."},{"key":"49711_CR44","doi-asserted-by":"crossref","unstructured":"Lim, J. J., Grinstein, S. & Roth, Z. Diversity and versatility of phagocytosis: roles in innate immunity, tissue remodeling, and homeostasis. Front Cell. Infect. Microbiol. 7, 191 (2017).","DOI":"10.3389\/fcimb.2017.00191"},{"key":"49711_CR45","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.3748\/wjg.v22.i4.1449","volume":"22","author":"JC Yoon","year":"2016","unstructured":"Yoon, J. C., Yang, C. M., Song, Y. & Lee, J. M. Natural killer cells in hepatitis C: current progress. World J. Gastroenterol. 22, 1449\u20131460 (2016).","journal-title":"World J. Gastroenterol."},{"key":"49711_CR46","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1172\/JCI200420985","volume":"114","author":"U Seifert","year":"2004","unstructured":"Seifert, U. et al. Hepatitis C virus mutation affects proteasomal epitope processing. J. Clin. Invest. 114, 250\u2013259 (2004).","journal-title":"J. Clin. Invest."},{"key":"49711_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/eji.201141593","volume":"42","author":"D Petrovic","year":"2012","unstructured":"Petrovic, D., Dempsey, E., Doherty, D. G., Kelleher, D. & Long, A. Hepatitis C virus \u2013 T-cell responses and viral escape mutations. Eur. J. Immunol. 42, 17\u201326 (2012).","journal-title":"Eur. J. Immunol."},{"key":"49711_CR48","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/vaccines9030291","volume":"9","author":"R Vel\u00e1zquez-Moctezuma","year":"2021","unstructured":"Vel\u00e1zquez-Moctezuma, R. et al. Mechanisms of hepatitis C virus escape from vaccine-relevant neutralizing antibodies. Vaccines (Basel). 9, 291 (2021).","journal-title":"Vaccines (Basel)"},{"key":"49711_CR49","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3748\/wjg.v10.i6.847","volume":"10","author":"HZ Guo","year":"2004","unstructured":"Guo, H. Z. et al. Sequence evolution of putative cytotoxic T cell epitopes in NS3 region of hepatitis C virus. World J. Gastroenterol. 10, 847 (2004).","journal-title":"World J. Gastroenterol."},{"key":"49711_CR50","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jhep.2016.07.042","volume":"65","author":"G Robaeys","year":"2016","unstructured":"Robaeys, G., Bielen, R., Azar, D. G., Razavi, H. & Nevens, F. Global genotype distribution of hepatitis C viral infection among people who inject drugs. J. Hepatol. 65, 1094\u20131103 (2016).","journal-title":"J. Hepatol."},{"key":"49711_CR51","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1016\/j.vaccine.2020.05.042","volume":"38","author":"T Donnison","year":"2020","unstructured":"Donnison, T. et al. Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes. Vaccine 38, 5036\u20135048 (2020).","journal-title":"Vaccine"},{"key":"49711_CR52","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2018.0281","author":"V Shahnazarian","year":"2018","unstructured":"Shahnazarian, V. Hepatitis C virus genotype 3: clinical features, current and emerging viral inhibitors, future challenges. Ann. Gastroenterol. https:\/\/doi.org\/10.20524\/aog.2018.0281 (2018).","journal-title":"Ann. Gastroenterol."},{"key":"49711_CR53","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1016\/j.ijid.2012.09.017","volume":"17","author":"H Aziz","year":"2013","unstructured":"Aziz, H. et al. Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Punjab Province in Pakistan and a phylogenetic analysis. Int. J. Infect. Dis. 17, e247\u2013e253 (2013).","journal-title":"Int. J. Infect. Dis."},{"key":"49711_CR54","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000351621","volume":"56","author":"S Akkarathamrongsin","year":"2013","unstructured":"Akkarathamrongsin, S. et al. Molecular epidemiology and genetic history of hepatitis C virus subtype 3a infection in Thailand. Intervirology 56, 284\u2013294 (2013).","journal-title":"Intervirology"},{"key":"49711_CR55","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/(SICI)1096-9071(199906)58:2<127::AID-JMV5>3.0.CO;2-K","volume":"58","author":"KA Harris","year":"1999","unstructured":"Harris, K. A., Gilham, C., Mortimer, P. P. & Teo, C. G. The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a. J. Med. Virol. 58, 127\u2013131 (1999).","journal-title":"J. Med. Virol."},{"key":"49711_CR56","first-page":"563","volume":"7","author":"A Naeem","year":"2017","unstructured":"Naeem, A. & Waheed, Y. Sequence analysis of hepatitis C virus nonstructural protein 3-4A serine protease and prediction of conserved B and T cell epitopes. Biomed. Rep. 7, 563\u2013566 (2017).","journal-title":"Biomed. Rep."},{"key":"49711_CR57","doi-asserted-by":"publisher","first-page":"103498","DOI":"10.1016\/j.jbi.2020.103498","volume":"108","author":"H Khalid","year":"2020","unstructured":"Khalid, H. & Ashfaq, U. A. Exploring HCV genome to construct multi-epitope based subunit vaccine to battle HCV infection: Immunoinformatics based approach. J. Biomed. Inf. 108, 103498 (2020).","journal-title":"J. Biomed. Inf."},{"key":"49711_CR58","doi-asserted-by":"publisher","first-page":"16107","DOI":"10.1038\/s41598-018-34254-5","volume":"8","author":"A Ikram","year":"2018","unstructured":"Ikram, A. et al. Exploring NS3\/4A, NS5A and NS5B proteins to design conserved subunit multi-epitope vaccine against HCV utilizing immunoinformatics approaches. Sci. Rep. 8, 16107 (2018).","journal-title":"Sci. Rep."},{"key":"49711_CR59","doi-asserted-by":"crossref","unstructured":"Molero-Abraham, M., Lafuente, E. M., Flower, D. R. & Reche, P. A. Selection of conserved epitopes from Hepatitis C virus for pan-populational stimulation of T-cell responses. Clin. Dev. Immunol. 2013, 1\u201310 (2013).","DOI":"10.1155\/2013\/601943"},{"key":"49711_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13721-021-00348-w","volume":"11","author":"V Agarwal","year":"2022","unstructured":"Agarwal, V., Tiwari, A. & Varadwaj, P. Prediction of suitable T and B cell epitopes for eliciting immunogenic response against SARS-CoV-2 and its mutant. Netw. Model. Anal. Health Inf. Bioinf. 11, 1 (2022).","journal-title":"Netw. Model. Anal. Health Inf. Bioinf."},{"key":"49711_CR61","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jhep.2014.08.026","volume":"62","author":"PT Losikoff","year":"2015","unstructured":"Losikoff, P. T. et al. HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients. J. Hepatol. 62, 48\u201355 (2015).","journal-title":"J. Hepatol."},{"key":"49711_CR62","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.apsb.2014.06.010","volume":"4","author":"M Huang","year":"2014","unstructured":"Huang, M., Jiang, J. D. & Peng, Z. Recent advances in the anti-HCV mechanisms of interferon. Acta Pharm. Sin B. 4, 241\u2013247 (2014).","journal-title":"Acta Pharm. Sin B"},{"key":"49711_CR63","doi-asserted-by":"publisher","first-page":"291075","DOI":"10.3389\/fimmu.2017.01508","volume":"8","author":"WC Yang","year":"2017","unstructured":"Yang, W. C. et al. Interleukin-4 supports the suppressive immune responses elicited by regulatory T cells. Front. Immunol. 8, 291075 (2017).","journal-title":"Front. Immunol."},{"key":"49711_CR64","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/pathogens14100989","volume":"14","author":"Z Guo","year":"2025","unstructured":"Guo, Z., He, Q., Zhang, Y., Li, Y. & Zhang, Z. Mechanisms of interleukin-10-mediated immunosuppression in viral infections. Pathogens 14, 989 (2025).","journal-title":"Pathogens"},{"key":"49711_CR65","doi-asserted-by":"publisher","first-page":"101335","DOI":"10.1016\/j.smim.2019.101335","volume":"44","author":"T Bedke","year":"2019","unstructured":"Bedke, T., Muscate, F., Soukou, S., Gagliani, N. & Huber, S. IL-10-producing T cells and their dual functions. Semin. Immunol. 44, 101335 (2019).","journal-title":"Semin. Immunol."},{"key":"49711_CR66","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1046\/j.1365-2249.1998.00690.x","volume":"113","author":"P Choi","year":"1998","unstructured":"Choi, P. & Reiser, H. IL-4: role in disease and regulation of production. Clin. Exp. Immunol. 113, 317 (1998).","journal-title":"Clin. Exp. Immunol."},{"key":"49711_CR67","doi-asserted-by":"publisher","first-page":"e1005193","DOI":"10.1371\/journal.ppat.1005193","volume":"11","author":"A Lee","year":"2015","unstructured":"Lee, A. et al. IL-4 induced innate CD8\u2009+\u2009T cells control persistent viral infection. PLoS Pathog.  11, e1005193 (2015).","journal-title":"PLoS Pathog."},{"key":"49711_CR68","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10989-022-10431-z","volume":"28","author":"MM Rahman","year":"2022","unstructured":"Rahman, M. M. et al. An immunoinformatics prediction of novel multi-epitope vaccines candidate against surface antigens of nipah virus. Int. J. Pept. Res. Ther. 28, 123 (2022).","journal-title":"Int. J. Pept. Res. Ther."},{"key":"49711_CR69","doi-asserted-by":"publisher","first-page":"10297","DOI":"10.1038\/s41598-024-61025-2","volume":"14","author":"J Sarvmeili","year":"2024","unstructured":"Sarvmeili, J., Baghban Kohnehrouz, B., Gholizadeh, A., Shanehbandi, D. & Ofoghi, H. Immunoinformatics design of a structural proteins driven multi-epitope candidate vaccine against different SARS-CoV-2 variants based on fynomer. Sci. Rep. 14, 10297 (2024).","journal-title":"Sci. Rep."},{"key":"49711_CR70","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s00262-022-03181-w","volume":"71","author":"A Samad","year":"2022","unstructured":"Samad, A. et al. Immune epitopes identification and designing of a multi-epitope vaccine against bovine leukemia virus: a molecular dynamics and immune simulation approaches. Cancer Immunol. Immunother. 71, 2535\u20132548 (2022).","journal-title":"Cancer Immunol. Immunother."},{"key":"49711_CR71","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/vaccines13030248","volume":"13","author":"J Li","year":"2025","unstructured":"Li, J., Ju, Y., Jiang, M., Li, S. & Yang, X. Y. Epitope-based vaccines: the next generation of promising vaccines against bacterial infection. Vaccines (Basel). 13, 248 (2025).","journal-title":"Vaccines (Basel)"},{"key":"49711_CR72","doi-asserted-by":"publisher","first-page":"100574","DOI":"10.1016\/j.imu.2021.100574","volume":"24","author":"A Shamakhi","year":"2021","unstructured":"Shamakhi, A. & Kordbacheh, E. Immunoinformatic design of an epitope-based immunogen candidate against Bacillus anthracis. Inf. Med. Unlocked. 24, 100574 (2021).","journal-title":"Inf. Med. Unlocked"},{"key":"49711_CR73","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","volume":"27","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2. Cell. Host Microbe 27, 671\u2013680e2 (2020).","journal-title":"Cell. Host Microbe"},{"key":"49711_CR74","doi-asserted-by":"crossref","unstructured":"Sharma, N., Naorem, L. D., Jain, S. & Raghava, G. P. S. ToxinPred2: an improved method for predicting toxicity of proteins. Brief Bioinform. 23, 174 (2022).","DOI":"10.1093\/bib\/bbac174"},{"key":"49711_CR75","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov, I., Bangov, I., Flower, D. R. & Doytchinova, I. AllerTOP v.2\u2014a server for in silico prediction of allergens. J. Mol. Model. 20, 2278 (2014).","journal-title":"J. Mol. Model."},{"key":"49711_CR76","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.vaccine.2006.09.032","volume":"25","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties. Vaccine 25, 856\u2013866 (2007).","journal-title":"Vaccine"},{"key":"49711_CR77","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/1471-2105-8-361","volume":"8","author":"HH Bui","year":"2007","unstructured":"Bui, H. H., Sidney, J., Li, W., Fusseder, N. & Sette, A. Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinform. 8, 361 (2007).","journal-title":"BMC Bioinform."},{"key":"49711_CR78","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1006\/smim.1995.0043","volume":"7","author":"PH Schafer","year":"1995","unstructured":"Schafer, P. H., Pierce, S. K. & Jardetzky, T. S. The structure of MHC class II: a role for dimer of dimers. Semin. Immunol. 7, 389\u2013398 (1995).","journal-title":"Semin. Immunol."},{"key":"49711_CR79","doi-asserted-by":"publisher","first-page":"7561","DOI":"10.3390\/ijms21207561","volume":"21","author":"DM Zajonc","year":"2020","unstructured":"Zajonc, D. M. Unconventional peptide presentation by classical MHC class I and implications for T and NK cell activation. Int. J. Mol. Sci. 21, 7561 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"49711_CR80","doi-asserted-by":"crossref","unstructured":"Schaap-Johansen, A. L., Vujovi\u0107, M., Borch, A., Hadrup, S. R. & Marcatili, P. T. Cell epitope prediction and its application to immunotherapy. Front. Immunol. 12, 712488 (2021).","DOI":"10.3389\/fimmu.2021.712488"},{"key":"49711_CR81","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1128\/JVI.01707-10","volume":"85","author":"M Richmond","year":"2011","unstructured":"Richmond, M. et al. Epitope mapping of HIV-specific CD8\u2009+\u2009T cell responses by multiple immunological readouts reveals distinct specificities defined by function. J. Virol. 85, 1275\u20131286 (2011).","journal-title":"J. Virol."},{"key":"49711_CR82","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1745-6150-8-30","volume":"8","author":"SK Dhanda","year":"2013","unstructured":"Dhanda, S. K., Vir, P. & Raghava, G. P. Designing of interferon-gamma inducing MHC class-II binders. Biol. Direct. 8, 30 (2013).","journal-title":"Biol. Direct"},{"key":"49711_CR83","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1128\/CDLI.8.3.628-631.2001","volume":"8","author":"SA Ghanekar","year":"2001","unstructured":"Ghanekar, S. A. et al. Gamma interferon expression in CD8 + T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65. Clin. Diagn. Lab. Immunol. 8, 628\u2013631 (2001).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"49711_CR84","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.4049\/jimmunol.175.7.4433","volume":"175","author":"H Nishikawa","year":"2005","unstructured":"Nishikawa, H. et al. IFN-\u03b3 controls the generation\/activation of CD4\u2009+\u2009CD25+ regulatory T cells in antitumor immune response. J. Immunol. 175, 4433\u20134440 (2005).","journal-title":"J. Immunol."},{"key":"49711_CR85","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/molecules28041687","volume":"28","author":"M Ismail","year":"2023","unstructured":"Ismail, M. et al. Experimental validation of MHC class I and II peptide-based potential vaccine candidates for human papilloma virus using Sprague-Dawly models. Molecules 28, 1687 (2023).","journal-title":"Molecules"},{"key":"49711_CR86","doi-asserted-by":"publisher","first-page":"456","DOI":"10.4049\/jimmunol.173.1.456","volume":"173","author":"F Liu","year":"2004","unstructured":"Liu, F., Whitton, J. L. & Slifka, M. K. The rapidity with which virus-specific CD8+ T cells initiate IFN-\u03b3 synthesis increases markedly over the course of infection and correlates with immunodominance. J. Immunol. 173, 456\u2013462 (2004).","journal-title":"J. Immunol."},{"key":"49711_CR87","doi-asserted-by":"crossref","unstructured":"de Ara\u00fajo-Souza, P. S., Hanschke, S. C. H. & Viola, J. P. B. Epigenetic control of interferon-Gamma expression in CD8 T cells. J. Immunol. Res. 2015,  1\u20137 (2015).","DOI":"10.1155\/2015\/849573"},{"key":"49711_CR88","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1089\/gtmb.2012.0221","volume":"17","author":"O Raha","year":"2013","unstructured":"Raha, O. et al. Role of HLA class II loci polymorphism in the manifestation of type 1 diabetes in a Bengali Indian patient population. Genet. Test. Mol. Biomarkers. 17, 52\u201361 (2013).","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"49711_CR89","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.meegid.2018.01.026","volume":"59","author":"A Zia","year":"2018","unstructured":"Zia, A., Abbasi, S. W., Ahmad, S., Zia, M. & Raza, A. Phylogenetic analysis, structure modeling and docking study of HCV NS3 protease for the identification of potent inhibitors. Infect. Genet. Evol. 59, 51\u201362 (2018).","journal-title":"Infect. Genet. Evol."},{"key":"49711_CR90","doi-asserted-by":"publisher","first-page":"e0008676","DOI":"10.1371\/journal.pntd.0008676","volume":"14","author":"SF Ahmed","year":"2020","unstructured":"Ahmed, S. F., Quadeer, A. A., Barton, J. P. & McKay, M. R. Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine. PLoS Negl. Trop. Dis. 14, e0008676 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"49711_CR91","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/jhep.2003.50115","volume":"37","author":"A Wertheimer","year":"2003","unstructured":"Wertheimer, A. Novel CD4\u2009+\u2009and CD8\u2009+\u2009T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. Hepatology 37, 577\u2013589 (2003).","journal-title":"Hepatology"},{"key":"49711_CR92","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jhep.2016.03.016","volume":"65","author":"S Lunemann","year":"2016","unstructured":"Lunemann, S. et al. Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C\u221703:04 and modulate NK cell function. J. Hepatol. 65, 252\u2013258 (2016).","journal-title":"J. Hepatol."},{"key":"49711_CR93","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00262-007-0284-5","volume":"56","author":"S Matsueda","year":"2007","unstructured":"Matsueda, S. et al. A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33. Cancer Immunol. Immunother. 56, 1359\u20131366 (2007).","journal-title":"Cancer Immunol. Immunother."},{"key":"49711_CR94","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.2174\/0929867328666211104093718","volume":"29","author":"AL Tornesello","year":"2022","unstructured":"Tornesello, A. L. et al. Profiling the HCV immune response in patients with chronic liver diseases and hepatocellular carcinoma by peptide microarray analysis. Curr. Med. Chem. 29, 2736\u20132747 (2022).","journal-title":"Curr. Med. Chem."},{"key":"49711_CR95","doi-asserted-by":"crossref","unstructured":"Grifoni, A. et al. T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species. J. Virol. 94, 1128 (2020).","DOI":"10.1128\/JVI.00089-20"},{"key":"49711_CR96","doi-asserted-by":"crossref","unstructured":"Elong Ngono, A., Shresta, S. & Cross-Reactive, T. Cell immunity to dengue and Zika viruses: new insights into vaccine development. Front. Immunol. 10, 256 (2019).","DOI":"10.3389\/fimmu.2019.01316"},{"key":"49711_CR97","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1016\/j.vaccine.2008.05.045","volume":"26","author":"P Fytili","year":"2008","unstructured":"Fytili, P. et al. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073. Vaccine 26, 3818\u20133826 (2008).","journal-title":"Vaccine"},{"key":"49711_CR98","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1128\/JVI.00155-08","volume":"82","author":"R Holtappels","year":"2008","unstructured":"Holtappels, R. et al. Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination. J. Virol. 82, 5781\u20135796 (2008).","journal-title":"J. Virol."},{"key":"49711_CR99","first-page":"630","volume":"368","author":"M Yuan","year":"2020","unstructured":"Yuan, M. et al. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Sci. (1979). 368, 630\u2013633 (2020).","journal-title":"Sci. (1979)"},{"key":"49711_CR100","doi-asserted-by":"crossref","unstructured":"Sanchez-Trincado, J. L., Gomez-Perosanz, M. & Reche, P. A. Fundamentals and methods for T- and B-cell epitope prediction. J. Immunol. Res. 2017, 1\u201314 (2017).","DOI":"10.1155\/2017\/2680160"},{"key":"49711_CR101","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12026-007-0020-4","volume":"38","author":"P Terasaki","year":"2007","unstructured":"Terasaki, P. I. A brief history of HLA. Immunol. Res. 38, 139\u2013148 (2007).","journal-title":"Immunol. Res."},{"key":"49711_CR102","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s002510050594","volume":"50","author":"A Sette","year":"1999","unstructured":"Sette, A. & Sidney, J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50, 201\u2013212 (1999).","journal-title":"Immunogenetics"},{"key":"49711_CR103","doi-asserted-by":"publisher","first-page":"8084","DOI":"10.1021\/acs.jpclett.0c02341","volume":"11","author":"SA Serapian","year":"2020","unstructured":"Serapian, S. A. et al. The answer lies in the energy: how simple atomistic molecular dynamics simulations may hold the key to epitope prediction on the fully glycosylated SARS-CoV-2 spike protein. J. Phys. Chem. Lett. 11, 8084\u20138093 (2020).","journal-title":"J. Phys. Chem. Lett."},{"key":"49711_CR104","doi-asserted-by":"crossref","unstructured":"Pastore, G. et al. Optimized protocol for the detection of multifunctional epitope-specific CD4\u2009+\u2009T cells combining MHC-II tetramer and intracellular cytokine staining technologies. Front. Immunol. 10, 2304 (2019).","DOI":"10.3389\/fimmu.2019.02304"},{"key":"49711_CR105","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1038\/s41467-019-11634-7","volume":"10","author":"AT Waickman","year":"2019","unstructured":"Waickman, A. T. et al. Dissecting the heterogeneity of DENV vaccine-elicited cellular immunity using single-cell RNA sequencing and metabolic profiling. Nat. Commun. 10, 3666 (2019).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49711-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49711-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49711-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:09:51Z","timestamp":1782720591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49711-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49711"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49711-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical clearance for this study was obtained from the Institutional Ethics Committee (No.-A-l\/2016-IEC and ICMR-NICED\/IEC-BMHR\/001\/2023) of the National Institute of Cholera and Enteric Diseases (Indian Council of Medical Research). All patients and volunteers gave their written consent for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No AI technology has been used to analyse the data or draw insights from the data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI in scientific writing"}}],"article-number":"19666"}}